Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
3.160
+0.140 (4.64%)
At close: Jan 22, 2026, 4:00 PM EST
3.150
-0.010 (-0.32%)
Pre-market: Jan 23, 2026, 4:22 AM EST
Absci Market Cap
Absci has a market cap or net worth of $475.17 million as of January 23, 2026. Its market cap has increased by 22.76% in one year.
Market Cap
475.17M
Enterprise Value
328.92M
1-Year Change
22.76%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $475.17M, an increase of 12.28%. That is a compound annual growth rate of 2.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 475.17M | -9.46% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 456.87M |
| Vanda Pharmaceuticals | 455.64M |
| NovaBridge Biosciences | 451.94M |
| Anavex Life Sciences | 449.42M |
| Solid Biosciences | 437.86M |
| ADC Therapeutics | 436.05M |
| 4D Molecular Therapeutics | 435.37M |
| Contineum Therapeutics | 432.87M |